TREM2 and Stroke: Accumulating evidence underscores the significant impact of the Triggering receptor expressed on myeloid cells-2 (TREM2)-activating protein of 12kDa (DAP12) system in central nervous system CNS disorders such as neurodegenerative diseases and stroke (136).